仁度生物取得耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增法专利，该方法能够高特异性、高灵敏度、低污染、快速地对含有MRSA的待测样品进行扩增，具有检测效率高，准确度高的特点

金融界06-18

金融界2024年6月18日消息，天眼查知识产权信息显示，上海仁度生物科技股份有限公司取得一项名为“一种耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增方法“，授权公告号CN110734988B，申请日期为2018年7月。专利摘要显示，本发明公开了一种耐甲氧西林金黄色葡萄球菌（Methicillin‑resistant Staphylococcus aureus，MRSA）核酸恒温扩增方法，具体地，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2444217381?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-18 13:15","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2444217381","market":"sh","top_or_hot":-1,"title":"仁度生物取得耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增法专利，该方法能够高特异性、高灵敏度、低污染、快速地对含有MRSA的待测样品进行扩增，具有检测效率高，准确度高的特点","media":"金融界","content":"<div>\n<p>金融界2024年6月18日消息，天眼查知识产权信息显示，上海仁度生物科技股份有限公司取得一项名为“一种耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增方法“，授权公告号CN110734988B，申请日期为2018年7月。专利摘要显示，本发明公开了一种耐甲氧西林金黄色葡萄球菌（Methicillin‑resistant Staphylococcus aureus，MRSA）核酸恒温扩增方法，具体地，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181319329f48fdc8&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>仁度生物取得耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增法专利，该方法能够高特异性、高灵敏度、低污染、快速地对含有MRSA的待测样品进行扩增，具有检测效率高，准确度高的特点</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n仁度生物取得耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增法专利，该方法能够高特异性、高灵敏度、低污染、快速地对含有MRSA的待测样品进行扩增，具有检测效率高，准确度高的特点\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-18 13:15 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181319329f48fdc8&s=b><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金融界2024年6月18日消息，天眼查知识产权信息显示，上海仁度生物科技股份有限公司取得一项名为“一种耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增方法“，授权公告号CN110734988B，申请日期为2018年7月。专利摘要显示，本发明公开了一种耐甲氧西林金黄色葡萄球菌（Methicillin‑resistant Staphylococcus aureus，MRSA）核酸恒温扩增方法，具体地，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181319329f48fdc8&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181319329f48fdc8&s=b","article_id":"2444217381","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181319329f48fdc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2444217381","pubTimestamp":1718687719,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"金融界2024年6月18日消息，天眼查知识产权信息显示，上海仁度生物科技股份有限公司取得一项名为“一种耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增方法“，授权公告号CN110734988B，申请日期为2018年7月。专利摘要显示，本发明公开了一种耐甲氧西林金黄色葡萄球菌（Methicillinresistant Staphylococcus aureus，MRSA）核酸恒温扩增方法，具体地，本","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688193":"仁度生物","BK0239":"医药制造"},"translate_title":"Rendu Biotech has obtained a patent for methicillin-resistant Staphylococcus aureus (MRSA) nucleic acid constant temperature amplification method. This method can quickly amplify samples containing MRSA with high specificity, high sensitivity, low pollution, and detection efficiency. High, high accuracy","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688193":1},"content_text":"金融界2024年6月18日消息，天眼查知识产权信息显示，上海仁度生物科技股份有限公司取得一项名为“一种耐甲氧西林金黄色葡萄球菌（MRSA）核酸恒温扩增方法“，授权公告号CN110734988B，申请日期为2018年7月。专利摘要显示，本发明公开了一种耐甲氧西林金黄色葡萄球菌（Methicillin‑resistant Staphylococcus aureus，MRSA）核酸恒温扩增方法，具体地，本发明方法包括步骤：在反应体系中进行扩增，所述的反应体系中含有扩增耐甲氧西林金黄色球菌（MRSA）的两个特异性引物对，所述引物可以从极低MRSA拷贝数的检测样品中扩增出对应于耐甲氧西林金黄色葡萄球菌（MRSA）的两个特征性序列（SA 23s rRNA和mecA RNA）的扩增产物。本发明方法能够高特异性、高灵敏度、低污染、快速地对含有MRSA（SA 23s rRNA和mecA RNA）的待测样品进行扩增，具有检测效率高，准确度高的特点，具有广阔的应用前景。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2444217381"}